The protective effect of exercise on diabetic nephropathy : the role of histidine-containing dipeptides

C

Infinets: The parallel syntax for non-wellfounded proof-theory

Logics based on the µ-calculus are used to model induc-tive and coinductive reasoning and to verify reactive systems. A well-structured proof-theory is needed in order to apply such logics to the study of programming languages with (co)inductive data types and automated (co)inductive theorem proving. While traditional proof system suffers some defects, non-wellfounded (or infinitary) and circular proofs have been recognized as a valuable alternative, and significant progress have been made in this direction in recent years. Such proofs are non-wellfounded sequent derivations together with a global validity condition expressed in terms of progressing threads. The present paper investigates a discrepancy found in such proof systems , between the sequential nature of sequent proofs and the parallel structure of threads: various proof attempts may have the exact threading structure while differing in the order of inference rules applications. The paper introduces infinets, that are proof-nets for non-wellfounded proofs in the setting of multiplicative linear logic with least and greatest fixed-points (µMLL ∞) and study their correctness and sequentialization. Inductive and coinductive reasoning is pervasive in computer science to specify and reason about infinite data as well as reactive properties. Developing appropriate proof systems amenable to automated reasoning over (co)inductive statements is therefore important for designing programs as well as for analyzing computational systems. Various logical settings have been introduced to reason about such inductive and coinductive statements, both at the level of the logical languages modelling (co)induction (such as Martin Löf's inductive predicates or fixed-point logics, also known as µ-calculi) and at the level of the proof-theoretical framework considered (finite proofs with explicit (co)induction rulesà la Park [23] or infinite, non-wellfounded proofs with fixed-point unfold-ings) [6-8, 4, 1, 2]. Moreover, such proof systems have been considered over classical logic [6, 8], intuitionistic logic [9], linear-time or branching-time temporal logic [19, 18, 25, 26, 13-15] or linear logic [24, 16, 4, 3, 14]

On the Proof Theory of Regular Fixed Points

International audienceWe consider encoding finite automata as least fixed points in a proof theoretical framework equipped with a general induction scheme, and study automata inclusion in that setting. We provide a coinductive characterization of inclusion that yields a natural bridge to proof-theory. This leads us to generalize these observations to regular formulas, obtaining new insights about inductive theorem proving and cyclic proofs in particular

THI safety system

International audienceFor several years, GANIL has been allowed to reach a maximum beam power of six kilowatts (400W in normal mode) thanks to the THI system (High Intensity Transport System). Three modes of running are necessary to accelerate a THI beam ("Injector" mode, "tuning" mode and "surveillance" mode). The "surveillance" mode requires a safety system to protect equipment against beam losses. Inside cyclotrons, diagnostics measure beam-loss currents at the injection and extraction devices. Along beam lines, diaphragms measure beam-loss currents at the input and output of dipoles. Current transformers are used for beam transmission measurements through beam lines and the cyclotrons. The safety system controls beam losses and quickly cuts the beam with a chopper if losses exceed thresholds. These thresholds can be seen and changed by software

Neonatal cephalohematoma

Background: A few hours after birth a newborn baby developed two soft well-defined bumps situated bilaterally on the posterior part of the parietal regions of the skull. The swellings were separated by the sagittal suture and do not cross the lambdoid suture. The infant was delivered vaginally in a head-first position after a full term pregnancy (G2A1P0) without complications. There was no prolonged labour nor use of forceps, vacuum extractor or other techniques of assisted delivery

A histologic study of the extracellular matrix during the development of glomerulosclerosis in murine chronic graft-versus-host disease.

The development of glomerulosclerosis was studied in murine chronic graft-versus-host disease (GvHD), which is a model for human systemic lupus erythematosus. The authors investigated the distribution patterns of six components of the extracellular matrix (ECM), i.e., laminin, fibronectin, collagen types I, III, IV, and VI during the course of the disease. All of these ECM components except collagen type I were found in the glomeruli of normal mice, where all of them were intrinsic constituents of the mesangium. Laminin, fibronectin, and collagen type IV were also found in the glomerular capillary walls. Starting 6 weeks after the induction of GvHD and continuing at week 8, the onset of an expansion of the mesangial matrix was observed. At the same time, the amounts of laminin, fibronectin, and collagen types IV and VI increased. Ten weeks after the onset of the disease, glomerulosclerosis developed. Traces of the interstitial collagen type I were found in sclerotic glomeruli. The levels of four ECM components, i.e., collagens III, IV, VI, and laminin were markedly decreased in the sclerotic glomeruli as compared with week 8. In contrast, the amount of fibronectin in the sclerotic glomeruli increased dramatically. Immunoelectron microscopic examination showed fibronectin in the sclerotic lesions, in contrast to laminin, collagen type I, and collagen type IV. It is concluded that the sclerotic lesions in murine chronic GvHD contain fibronectin. The small amounts of the ECM components laminin, as well as collagens III, IV, and VI in the sclerotic glomeruli in GvHD, might represent remnants of mesangial material and collapsed capillary walls. These components are probably replaced by increased production and/or accumulation of collagen type I and fibronectin

Recent developments for beam intensity increase operation

International audienceThe aim of the beam intensity increase operation (THI project) is to multiply the present intensities for lightest ions by a factor of fifteen in order to reach maximum power of six kilowatts [1]. The main objective is the production of large amounts of rare isotopes, either with SISSI (device intended for producing radioactive beams), or with SPIRAL (production and acceleration of radioactive ion beams). As part of this THI project, new developments have been required such as spiral scanners, for beanl profile measurements, and safety system to protect equipments against beam losses. Other developments are being carried on to improve the high intensity beam operation

The VEGF-A inhibitor sFLT-1 improves renal function by reducing endothelial activation and inflammation in a mouse model of type 1 diabetes

Immunopathology of vascular and renal diseases and of organ and celltransplantatio

Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier

In this study, the effect of heterozygous germline mutations in the heparan sulfate (HS) glycosaminoglycan chain co-polymerases EXT1 and EXT2 on glomerular barrier function and the endothelial glycocalyx in humans is investigated. Heparan sulfate (HS) glycosaminoglycans are deemed essential to the glomerular filtration barrier, including the glomerular endothelial glycocalyx. Animal studies have shown that loss of HS results in a thinner glycocalyx. Also, decreased glomerular HS expression is observed in various proteinuric renal diseases in humans. A case report of a patient with an EXT1 mutation indicated that this could result in a specific renal phenotype. This patient suffered from multiple osteochondromas, an autosomal dominant disease caused by mono-allelic germline mutations in the EXT1 or EXT2 gene. These studies imply that HS is indeed essential to the glomerular filtration barrier. However, loss of HS did not lead to proteinuria in various animal models. We demonstrate that multiple osteochondroma patients do not have more microalbuminuria or altered glycocalyx properties compared to age-matched controls (n = 19). A search for all Dutch patients registered with both osteochondroma and kidney biopsy (n = 39) showed that an EXT1 or EXT2 mutation does not necessarily lead to specific glomerular morphological phenotypic changes. In conclusion, this study shows that a heterozygous mutation in the HS backbone elongating enzymes EXT1 and EXT2 in humans does not result in (micro)albuminuria, a specific renal phenotype or changes to the endothelial glycocalyx, adding to the growing knowledge on the role of EXT1 and EXT2 genes in pathophysiology.Nephrolog